Pediatric AKI/CRRT 2012 Conference: Novel therapies and studies in AKI

Novel therapies mentioned at the conference for acute kidney injury (AKI) in future

  • p53 si RNA
  • Deferipone
  • Alpha MSH
  • Mesenchymal stem cells

Translational Research Investigating Biomarkers and Endpoints for Acute Kidney Injury (TRIBE-AKI) Consortium.

Look out for the ASSESS-AKI Study Results

  • The Assessment, Serial Evaluation, and Subsequent Sequelae of Acute Kidney Injury (ASSESS-AKI) Study was established to examine how a hospitalized episode of AKI independently affects the risk of chronic kidney disease development and progression, cardiovascular events, death, and other important patient-centered outcomes. This prospective study will enroll a cohort of 1100 adult participants with a broad range of AKI and matched hospitalized participants without AKI at three Clinical Research Centers, as well as 100 children undergoing cardiac surgery at three Clinical Research Centers.

Sidharth Kumar Sethi, MD
eAJKD Advisory Board member

Check out all of eAJKD’s coverage of the AKI in Children / PCRRT 2012 Conference here.

1 Comment on Pediatric AKI/CRRT 2012 Conference: Novel therapies and studies in AKI

  1. Dear all, see also the paper:
    Nephrol Dial Transplant (2010) 25: 3167–3169
    doi: 10.1093/ndt/gfq504
    Advance Access publication 13 August 2010
    Translational Nephrology
    Urinary biomarkers—silver bullets to faster drug development and
    nephron protection
    Michael Haase and Peter R. Mertens

1 Trackback / Pingback

  1. Recap of eAJKD’s coverage of the Pediatric AKI/CRRT 2012 Conference –

Leave a Reply

%d bloggers like this: